| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/16/2001 | EP1098902A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | CN1295079A Liquid phase synthesis process of peptide chain containing glutamine and asparamide and its intermediate |
| 05/16/2001 | CN1065874C Novel peptides, preparation and use thereof |
| 05/15/2001 | US6232468 Antiinflammatory agent |
| 05/15/2001 | US6232438 Angiotensin converting enzyme inhibitors |
| 05/15/2001 | US6232342 Protease inhibitors |
| 05/15/2001 | US6232305 Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 05/15/2001 | CA2291456A1 Diagnostic agents for pancreatic exocrine function |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032836A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/10/2001 | WO2001032691A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | WO2001032690A1 Substituted dipeptides having nos inhibiting activity |
| 05/10/2001 | WO2001032689A1 Salts of enalapril |
| 05/10/2001 | WO2001032684A2 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 05/10/2001 | WO2000033888A9 Prodrug compounds and process for preparation thereof |
| 05/10/2001 | CA2389543A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | CA2388354A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/09/2001 | EP1097164A1 Processes for coupling amino acids using bis-(trichloromethyl) carbonate |
| 05/09/2001 | EP1096939A1 Nocathiacin antibiotics |
| 05/09/2001 | EP1096925A2 Use of inhibitors of prenyltransferases for for inhibiting fungal growth |
| 05/08/2001 | US6228986 Reductive alkylation of alpha-nitrogen of resin-bound protected lysine, acylation with protected-amino acid, deblocking, acylating with substituted succinic anhydride, removing protection from lysine, then cyclization |
| 05/08/2001 | US6228983 Peptides from transmembrane protein, gp41, from human immunodeficiency virus; viricides; drug screening; intracellular modulators of coiled-coil peptide structures |
| 05/08/2001 | US6228858 2,5-methylol-3,6-(aminomethyl)-hydroquinone; diabetes nephropathy; controlling blood sugar |
| 05/08/2001 | US6228854 Selective factor Xa inhibitors |
| 05/08/2001 | US6228841 Peptide derivatives |
| 05/08/2001 | US6228374 Polypeptides and immunology |
| 05/08/2001 | US6228373 Peptide dimer, glycine, cystine or prolne amino acid for immunology |
| 05/03/2001 | WO2001030807A1 Process for the preparation of a dipeptide and intermediate product in such a process |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | CA2389024A1 Process for the preparation of a dipeptide and intermediate product in such a process |
| 05/02/2001 | EP1096011A1 Microbiological production method for alpha-l-aspartyl-l-phenylalanine |
| 05/02/2001 | EP1095061A1 Peptides based on the sequence of human lactoferrin and their use |
| 05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/01/2001 | US6225493 Contacting mixture of alpha- and beta-isomers of neotame and organic solvent with aqueous metal ion such that beta-isomer chelates metal ion and forms metal complex, partitioning metal complex from alpha-isomer |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | US6225287 Crystalline forms |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029067A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 04/26/2001 | WO2001029066A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | WO2001029065A1 Process for preparing peptide intermediates |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028577A2 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 04/26/2001 | WO2001028362A1 Use of n-`n-(3,3 dimethylbutyl)-l-alpha-aspartyl-l-phenylalanine 1-methyl ester (neotame) to modify mouthfeel perception |
| 04/26/2001 | WO2000061609B1 Prodrugs of thrombin inhibitors |
| 04/26/2001 | WO2000061574A3 Method for producing thiophenyl-amidines |
| 04/26/2001 | CA2388357A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 04/26/2001 | CA2388315A1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | CA2387995A1 Process for preparing peptide intermediates |
| 04/26/2001 | CA2387559A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | CA2385958A1 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/25/2001 | EP1094074A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses |
| 04/25/2001 | EP1093463A1 A method for preparing a compound with growth hormone releasing properties |
| 04/25/2001 | EP1093460A1 Dolastatin 15 derivatives |
| 04/25/2001 | EP1093458A1 Process for the preparation of resin-bound cyclic peptides |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292700A IgE antibody production inhibitors and autoimmune diseases inhibitors |
| 04/24/2001 | US6222013 Esterifying amino acid or peptide by mixing with alkanol and chlorosulfonic acid; alcohol reacts with chlorosulfonic acid to form a hydrosulfate which then reacts with amino acid or peptide for form corresponding ester |
| 04/24/2001 | US6221897 Hypolipidemics. |
| 04/24/2001 | US6221888 Antihistamine, antiinflammatory agent, autoimmune disease, rheumatic disorders |
| 04/24/2001 | US6221846 Ophthalmic drug compositions |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/19/2001 | WO2001027261A2 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | WO2001027242A2 Methods for identifying inhibitors of methionine aminopeptidases |
| 04/19/2001 | WO2001027142A1 Process for producing aspartame derivative, crystals thereof, novel production intermediates therefor and process for producing the intermediate |
| 04/19/2001 | WO2001027141A1 Inhibitors of factor xa having an arginine or arginine aldehyde mimic |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | WO2001027138A2 Modulators of srebp processing |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 04/19/2001 | WO2001027077A2 Hydroxysulfonylalkylene-, phosphonoalkylene- or difluoro(phosphononon)methyl- substituted benzene, or benzofuran derivatives as non-peptidic cdc25 inhibitors |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2388991A1 Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino |
| 04/19/2001 | CA2387126A1 Methods for identifying inhibitors of methionine aminopeptidases |
| 04/19/2001 | CA2386859A1 Process for production of aspartame derivative, crystal thereof, novel production intermediate therefor, and process for production of intermediate thereof |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/18/2001 | EP1092724A2 Angiotensin converting enzyme inhibitor |
| 04/18/2001 | EP1091953A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 04/18/2001 | EP1091932A1 Chiral stationary phases for enantiomers separation and their preparation |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 04/18/2001 | CN1291994A New salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-2-(methylcarbamoyl)-2-phenylethyl) carbamoyl)-2-(2-naphtyl) ethyl) amide |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218398 Nocathiacin antibiotics |
| 04/17/2001 | US6218382 For prophylaxis or therapy of thrombosis |
| 04/17/2001 | US6218365 Serine protease inhibitors |
| 04/17/2001 | US6218364 Fluorinated neurokinin A antagonists |
| 04/17/2001 | US6217846 Synthetic peptides for use in thrombus detection |
| 04/17/2001 | CA2156742C Phosphonomethyldipeptides |
| 04/17/2001 | CA2152267C Difluoro-pentapeptide derivative anti-inflammatory agents |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |